TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication

OBJECTIVE: We investigated the mutational landscape of mammalian target of rapamycin (mTOR) signalling cascade in hepatocellular carcinomas (HCCs) with chronic HBV background, aiming to evaluate and delineate mutation-dependent mechanism of mTOR hyperactivation in hepatocarcinogenesis. DESIGN: We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Daniel W H, Chan, Lo K, Chiu, Yung T, Xu, Iris M J, Poon, Ronnie T P, Cheung, Tan T, Tang, Chung N, Tang, Victor W L, Lo, Irene L O, Lam, Polly W Y, Yau, Derek T W, Li, Miao X, Wong, Chun M, Ng, Irene O L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530480/
https://www.ncbi.nlm.nih.gov/pubmed/27974549
http://dx.doi.org/10.1136/gutjnl-2016-312734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530480/
https://www.ncbi.nlm.nih.gov/pubmed/27974549
http://dx.doi.org/10.1136/gutjnl-2016-312734

Ejemplares similares